“Patient-Level, Visit-by-Visit Data Highlight the Extent of Skin and Itch Improvement in Atopic Dermatitis With Lebrikizumab” (2023) SKIN The Journal of Cutaneous Medicine, 7(6), p. s275. doi:10.25251/skin.7.supp.275.